CVE-2024-11154

PublishPress Revisions: Duplicate Posts, Submit, Approve and Schedule Content Changes <= 3.5.15 - Missing Authorization to Authenticated (Subscriber+) Sensitive Information Exposure

Description

The PublishPress Revisions: Duplicate Posts, Submit, Approve and Schedule Content Changes plugin for WordPress is vulnerable to Sensitive Information Exposure in all versions up to, and including, 3.5.15 via the 'actAjaxRevisionDiffs' function. This makes it possible for authenticated attackers, with Subscriber-level access and above, to extract sensitive data including revisions of posts and pages.

Category

4.3
CVSS
Severity: Medium
CVSS 3.1 •
EPSS 0.06%
Affected: kevinb PublishPress Revisions: Duplicate Posts, Submit, Approve and Schedule Content Changes
Published at:
Updated at:

References

Frequently Asked Questions

What is the severity of CVE-2024-11154?
CVE-2024-11154 has been scored as a medium severity vulnerability.
How to fix CVE-2024-11154?
To fix CVE-2024-11154, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2024-11154 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2024-11154 is being actively exploited. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2024-11154?
CVE-2024-11154 affects kevinb PublishPress Revisions: Duplicate Posts, Submit, Approve and Schedule Content Changes.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.